Clinical Trial Update: Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide [Phase 2]

View source ↗

Summary

A Phase 2 trial using functional MRI to assess hypothalamic activation in response to diazoxide in adults with Type 2 diabetes; the study was terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Metabolism Disorders
• Type 2 Diabetes Mellitus

Drugs mentioned

• DIAZOXIDE (DIAZOXIDE)

Snippet

Sponsor: Meredith Hawkins | Conditions: Diabetes Mellitus, Type 2, Glucose, High Blood | Phase 2 | Status: TERMINATED | Results posted: 2025-05-31